Abstract: An improved process of preparing hydroxy-terminated aliphatic polyethers having pendant alkyl azide groups is disclosed. The process entails reacting metal azide and hydroxy-terminated aliphatic polyether having pendant haloalkyl groups at elevated temperatures. The improvement comprises using a liquid reaction medium that is relatively non-polar and comprises a polyalkyleneoxide having (a) a molecular weight above about 200 and (b) miscibility with the hydroxy-terminated aliphatic polyether having pendant haloalkyl groups at temperatures greater than about 80.degree. C.

Abstract: Polymerizing 3,3-bischloromethyloxetane to yield halomethyl polymer products having hydroxy functionality and a molecular weight between about 500-15,000 followed by reacting such products with metal azide provides poly(azidomethyloxetanes) particularly useful as energetic binders for explosives, gas generators and gun and rocket propellants. Polyhydric initiators are used in the polymerization step.

Abstract: Novel compounds of the formula ##SPC1##Wherein R is selected from the group consisting of carboxamidine, carboxylic acid, carboxamide, methyl formimidate, thiocarboxamide, carboxamidoxime, carboxamidrazone, and cyano. The compounds have been demonstrated to be useful by having a degree of antimetabolic activity.

Abstract: An improved method for synthesizing 1-(tetrahydro - 2-furanyl) - 5-fluorouracil from a silyl derivitive of 5-fluorouracil (bis - trimethylsilyl 5-fluorouracil) by reacting the same with 2-chlorotetrahydrofuran. The reaction is carried out at controlled conditions of temperature and under an inert gas. Yields in excess of 80% of the theoretical are obtained as calculated upon the starting amounts of 5-fluorouracil.

Abstract: A facile process for the production of Ftorafur [1-(tetrahydro-2-furanyl)-5-fluorouracil] which comprises reacting 2,4-bis-trimethylsilyl uracil with 2-chlorotetrahydrofuran to produce 1-tetrahydro-2-furanyluracil at low temperatures in a dry non-aqueous solvent, e.g. a halogenated hydrocarbon solvent such as methylene chloride. Subsequently the desired final product is produced by direct fluorination of the uracil ring as the last step utilizing a fluorinating agent such as trifluoromethylhypofluorite. This step is conducted in the cold and again in the presence of a halogenated hydrocarbon solvent such as chloroform. Ftorafur has been utilized as a pyrimidine analog for the management of carcinoma in the breast and large intestine and with less side effects than 5-fluorouracil (5-FU).